These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 19748832

  • 21. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 22. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus.
    Ju S, Zhang D, Wang Y, Ni H, Kong X, Zhong R.
    Clin Biochem; 2006 Dec; 39(12):1131-7. PubMed ID: 17069785
    [Abstract] [Full Text] [Related]

  • 23. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.
    Ishii T, Onda H, Tanigawa A, Ohshima S, Fujiwara H, Mima T, Katada Y, Deguchi H, Suemura M, Miyake T, Miyatake K, Kawase I, Zhao H, Tomiyama Y, Saeki Y, Nojima H.
    DNA Res; 2005 Dec; 12(6):429-39. PubMed ID: 16769699
    [Abstract] [Full Text] [Related]

  • 24. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
    Landolt-Marticorena C, Bonventi G, Lubovich A, Ferguson C, Unnithan T, Su J, Gladman DD, Urowitz M, Fortin PR, Wither J.
    Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188
    [Abstract] [Full Text] [Related]

  • 25. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 26. [Expression of transcription factors T-bet and GATA-3 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Peng XB, Deng Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2138-9. PubMed ID: 19861286
    [Abstract] [Full Text] [Related]

  • 27. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.
    Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
    [Abstract] [Full Text] [Related]

  • 28. Negative relationship between expression of glucocorticoid receptor alpha and disease activity: glucocorticoid treatment of patients with systemic lupus erythematosus.
    Li X, Zhang FS, Zhang JH, Wang JY.
    J Rheumatol; 2010 Feb; 37(2):316-21. PubMed ID: 20032106
    [Abstract] [Full Text] [Related]

  • 29. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
    Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA, Lauwerys BR.
    Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
    [Abstract] [Full Text] [Related]

  • 30. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 31. Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients.
    Tsuzaka K, Takeuchi T, Onoda N, Pang M, Abe T.
    J Autoimmun; 1998 Oct; 11(5):381-5. PubMed ID: 9802920
    [Abstract] [Full Text] [Related]

  • 32. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [Abstract] [Full Text] [Related]

  • 33. Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.
    Sthoeger ZM, Sharabi A, Molad Y, Asher I, Zinger H, Dayan M, Mozes E.
    J Autoimmun; 2009 Aug; 33(1):77-82. PubMed ID: 19346102
    [Abstract] [Full Text] [Related]

  • 34. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
    Lu LY, Chu JJ, Lu PJ, Sung PK, Hsu CM, Tseng JC.
    J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
    [Abstract] [Full Text] [Related]

  • 35. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S, Dolff S, Kribben A, Dürig J, Patschan D, Wilde B, Specker C, Philipp T, Witzke O.
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
    Hillion S, Garaud S, Devauchelle V, Bordron A, Berthou C, Youinou P, Jamin C.
    Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
    [Abstract] [Full Text] [Related]

  • 37. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.
    Kimkong I, Avihingsanon Y, Hirankarn N.
    Lupus; 2009 Oct; 18(12):1066-72. PubMed ID: 19762380
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
    Lauwerys BR, Garot N, Renauld JC, Houssiau FA.
    Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
    [Abstract] [Full Text] [Related]

  • 39. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, Takasaki Y.
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [Abstract] [Full Text] [Related]

  • 40. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N.
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.